Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies - A Prospective Interventional Study.

NCT06347029 is registered in ClinicalTrials.gov with Brugmann University Hospital as lead sponsor.

NCT NCT06347029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06347029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies - A Prospective Interventional Study.
Lead sponsor
Brugmann University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 17, 2023
Completion date
December 31, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic renal failure